Cargando…

The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients

PURPOSE: To assess the incidence of chemotherapy-induced ovarian function failure (COFF) based on estradiol and follicle stimulating hormone (FSH) monitoring in premenopausal women with hormone-receptor positive breast cancer treated with second and third generation (neo-)adjuvant chemotherapy. RESU...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vriens, Ingeborg J.H., De Bie, Ashley J.R., Aarts, Maureen J.B., de Boer, Maaike, van Hellemond, Irene E.G., Roijen, Joyce H.E., van Golde, Ron J.T., Voogd, Adri C., Tjan-Heijnen, Vivianne C.G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355271/ https://www.ncbi.nlm.nih.gov/pubmed/28076330 http://dx.doi.org/10.18632/oncotarget.14532

Ejemplares similares

Axillary staging in breast cancer patients treated with neoadjuvant chemotherapy in two Dutch phase III studies
por: Vriens, Birgit E.P., et al.
Publicado: (2017)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

What to Do with Non-visualized Sentinel Nodes? A Dutch Nationwide Survey Study
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Cost and cost-effectiveness of adjuvant trastuzumab in the real world setting: A study of the Southeast Netherlands Breast Cancer Consortium
por: Seferina, Shanly C., et al.
Publicado: (2017)

Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure
por: Verheuvel, Nicole C., et al.
Publicado: (2017)

Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

Trends in frequency and outcome of high‐risk breast lesions at core needle biopsy in women recalled at biennial screening mammography, a multiinstitutional study
por: Luiten, Jacky D., et al.
Publicado: (2019)

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer
por: van Hellemond, Irene E. G., et al.
Publicado: (2018)

Frequency and diagnostic outcome of bilateral recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study
por: de Ruijter, Tim C., et al.
Publicado: (2019)

Impact of the second reader on screening outcome at blinded double reading of digital screening mammograms
por: Coolen, Angela M. P., et al.
Publicado: (2018)

Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
por: Luiten, Jacky D., et al.
Publicado: (2021)

SUBMIT: Systemic therapy with or without up front surgery of the primary tumor in breast cancer patients with distant metastases at initial presentation
por: Ruiterkamp, Jetske, et al.
Publicado: (2012)

Counseling young women with early breast cancer on fertility preservation
por: ter Welle-Butalid, M. E. (Elena), et al.
Publicado: (2019)

Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands
por: Lameijer, Joost R. C., et al.
Publicado: (2020)

The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches
por: Lobbezoo, Dorien, et al.
Publicado: (2016)

Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study
por: van Hellemond, Irene E.G., et al.
Publicado: (2019)

Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
por: Vriens, Ingeborg J. H., et al.
Publicado: (2020)

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
por: Schneider, Paul Peter, et al.
Publicado: (2021)

Interval breast cancer characteristics before, during and after the transition from screen-film to full-field digital screening mammography
por: van Bommel, Rob M. G., et al.
Publicado: (2017)

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial
por: Tjan-Heijnen, Vivianne C.G., et al.
Publicado: (2023)

Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2021)

Healthcare Use during the Last Six Months of Life in Patients with Advanced Breast Cancer
por: Schmitz, Renée. S. J. M., et al.
Publicado: (2021)

Improved survival for sequentially as opposed to concurrently delivered neoadjuvant chemotherapy in non-metastatic breast cancer
por: Vriens, B. E. P. J., et al.
Publicado: (2017)

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry
por: Meegdes, Marissa, et al.
Publicado: (2021)

Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool
por: van den Hoven, Ingrid, et al.
Publicado: (2019)

The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer
por: Lammers, Senna W M, et al.
Publicado: (2023)

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
por: de Ruijter, Tim C., et al.
Publicado: (2020)

Clinical value of contralateral breast cancers detected by pre-operative MRI in patients diagnosed with DCIS: a population-based cohort study
por: Keymeulen, Kristien B. I. M., et al.
Publicado: (2022)

Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study
por: Deckx, Laura, et al.
Publicado: (2015)

Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial
por: van Hellemond, Irene E. G., et al.
Publicado: (2020)

Trends in Overall Survival and Treatment Patterns in Two Large Population-Based Cohorts of Patients with Breast and Colorectal Cancer
por: van Abbema, Doris, et al.
Publicado: (2019)

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands
por: Schneider, Paul P., et al.
Publicado: (2020)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

Correction to: Frequency and characteristics of contralateral breast abnormalities following recall at screening mammography
por: Lameijer, Joost R. C., et al.
Publicado: (2018)

Quality of life in a real-world cohort of advanced breast cancer patients: a study of the SONABRE Registry
por: Claessens, Anouk K. M., et al.
Publicado: (2020)

CD44 enhances tumor aggressiveness by promoting tumor cell plasticity
por: Paulis, Yvette W.J., et al.
Publicado: (2015)

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry
por: Ibragimova, Khava I. E., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l8io6nkevocebejt6sb1knav19